Home page > Communicable diseases and health threats

antibiotic


Please find all related articles below.



The vital role of health professionals in curbing drug-resistant infections


About one third of hospital patients are prescribed antibiotics and up to 50% of their use is unnecessary or inappropriate. ECDC data clearly reveals the causal association between the indiscriminate use of antibiotics and the spread of drug-resistant infections, also known as antimicrobial resistance (AMR). Whilst some EU countries have made significant strides in control of drug-resistant infections, overuse and the spread of AMR urgently need to be addressed in others. As drug-resistant (...)
06/04/2016

European Parliament votes on the use of antibiotics for farm animals


Recent European Parliament votes on Veterinary Medicinal Products and Medicated Feed, and the adoption of the Animal Health Law are vital steps in tackling the spread of drug-resistant infections (antimicrobial resistance, AMR). Calls from public health experts to limit the prophylactic use of antimicrobials in farm animals have been a longstanding issue given that the majority of antibiotics are given to livestock. By Sascha Marschang, Policy Manager for Health Systems, EPHA. Votes on (...)
06/04/2016

[EVENT REPORT] Pharma Pollution: An ignored cause of Antimicrobial Resistance


As the European Commission undertakes its evaluation of the expiring Action Plan on Antimicrobial Resistance (AMR), the joint EPHA - Health Care Without Harm Europe (HCWH) event of 10 December called for a much stronger consideration of the environmental dimension of AMR. A detailed event report is now available. The event was hosted by MEPs Martin Häusling (Greens, Germany) and Jasenko Selimovic (ALDE, SWE). Both MEPs underlined the need for urgent action, with MEP Selimovic concluding (...)
02/03/2016

Environmental pollution: Neglected dimension of AMR


On 10 December 2015, EPHA and Health Care Without Harm Europe organised an event that discussed the link between AMR and environmental pollution, focusing on antibiotics manufacturing and animal husbandry. The event established that all stakeholders - in particular industry and regulators - must push for enforceable standards and regulation. A new EPHA report further develops this theme. Why is the environment neglected in AMR debates? Despite a number of scandals and growing evidence (...)
28/12/2015

World Antibiotic Awareness Week: High time for global policy action


Antimicrobial Resistance (AMR) is a global health threat of unprecented scale and urgency. During the first World Antibiotic Awareness Week (WAAW) from 16-22 November 2015, which encompassed the 8th European Antibiotic Awareness Day (EAAD), emphasis was placed on the global nature of the emergency that requires all institutions and actors to join forces. At the launch event in Brussels, the European Commission, ECDC and WHO sent a clear signal that only effective collaboration can tackle (...)
07/12/2015

[Events] Pharma Pollution: An Ignored Cause of Antimicrobial Resistance


Join EPHA, Health Care Without Harm, and MEP hosts Martin Hausling (Greens/EFA) and Jasenko Selimovic (ALDE) to discuss a long-neglected cause of antimicrobial resistance (AMR) - pollution of the natural environment arising from irresponsible antibiotic manufacturing and untransparent global supply chains, as well as from the overuse of antibiotics in veterinary medicine. Speakers will include representatives from civil society, the pharmaceutical industry, as well as EU and international (...)
17/11/2015

[Press release] European Antibiotic Awareness Day: Fighting ‘superbugs’ to save lives


Brussels, 18 November – Today marks the 7th European Antibiotic Awareness Day (EAAD) (1) which promotes a more prudent use of antibiotics to tackle the growing challenge of multi-drug resistant ‘superbugs’ (2). Around 25,000 patients die every year in the European Union (EU) as a result of infections caused by antibiotic-resistant bacteria. Preventing the spread of antibiotic resistance will lead to significant health service savings since related costs amount to (...)
20/11/2014

Keeping Antimicrobial Resistance (AMR) on the radar screen, year-round


The global problem of Antimicrobial Resistance (AMR) demands the continuous attention of the public health community beyond the annual focus of the European Antibiotic Awareness Day (marked annually on 18 November). EPHA is committed to raising awareness of AMR-related concerns, including the reduction of antibiotics use, to ensure that people living in Europe can continue to benefit from life-saving antibiotics. Moreover, it is important to promote policy coherence, as well as effective, (...)
22/05/2014

[EPT] Antimicrobial Resistance (AMR) – EP report: EU-wide plan to tackle the proliferation of AMR (7 November 2013)


Antimicrobial Resistance (AMR) Antimicrobial Resistance (AMR) – EP report - EU-wide plan to tackle the proliferation of AMR Antimicrobial resistance (AMR) has been described as one of the biggest threats to public health - a worrisome development since resistance to drugs designed to treat severe diseases is becoming more widespread. In 2001 the WHO published its Global Strategy for Containment of Antimicrobial Resistance, describing what AMR is and what strategies should be (...)
22/03/2013

UK Chief Medical Officer warns of danger of Antimicrobial Resistance


The threat posed by growing antimicrobial resistance (AMR), should be considered as serious as terrorism, according to the UK’s Chief Medical Officer (CMO), Professor Dame Sally Davies. In an interview with the Guardian newspaper, Professor Davies urged the British government to raise the issue at the upcoming G8 Summit and warned that AMR poses a ’catastrophic threat’ to the population. Mirroring comments made by the WHO, she added that, unless concrete steps are taken (...)
14/03/2013